These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 31586016

  • 1. Investigation of diagnostic performance of five urinary cholesterol metabolites for Niemann-Pick disease type C.
    Maekawa M, Jinnoh I, Narita A, Iida T, Saigusa D, Iwahori A, Nittono H, Okuyama T, Eto Y, Ohno K, Clayton PT, Yamaguchi H, Mano N.
    J Lipid Res; 2019 Dec; 60(12):2074-2081. PubMed ID: 31586016
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann-Pick disease type C.
    Maekawa M, Narita A, Jinnoh I, Iida T, Marquardt T, Mengel E, Eto Y, Clayton PT, Yamaguchi H, Mano N.
    Clin Chim Acta; 2019 Jul; 494():58-63. PubMed ID: 30876856
    [Abstract] [Full Text] [Related]

  • 3. LC/ESI-MS/MS analysis of urinary 3β-sulfooxy-7β-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann-Pick type C disease.
    Maekawa M, Misawa Y, Sotoura A, Yamaguchi H, Togawa M, Ohno K, Nittono H, Kakiyama G, Iida T, Hofmann AF, Goto J, Shimada M, Mano N.
    Steroids; 2013 Oct; 78(10):967-72. PubMed ID: 23751200
    [Abstract] [Full Text] [Related]

  • 4. Development of a Highly Sensitive and Rapid Liquid Chromatography-Tandem Mass Spectrometric Method Using a Basic Mobile Phase Additive to Determine the Characteristics of the Urinary Metabolites for Niemann-Pick Disease Type C.
    Maekawa M, Miyoshi K, Narita A, Sato T, Sato Y, Kumondai M, Kikuchi M, Higaki K, Okuyama T, Eto Y, Sakamaki H, Mano N.
    Biol Pharm Bull; 2022 Oct; 45(9):1259-1268. PubMed ID: 36047194
    [Abstract] [Full Text] [Related]

  • 5. Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3β-hydroxysteroid dehydrogenase deficiency.
    Maekawa M, Shimada M, Ohno K, Togawa M, Nittono H, Iida T, Hofmann AF, Goto J, Yamaguchi H, Mano N.
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):576-87. PubMed ID: 25575700
    [Abstract] [Full Text] [Related]

  • 6. Biomarker analysis of Niemann-Pick disease type C using chromatography and mass spectrometry.
    Maekawa M, Iwahori A, Mano N.
    J Pharm Biomed Anal; 2020 Nov 30; 191():113622. PubMed ID: 32998104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease.
    Mazzacuva F, Mills P, Mills K, Camuzeaux S, Gissen P, Nicoli ER, Wassif C, Te Vruchte D, Porter FD, Maekawa M, Mano N, Iida T, Platt F, Clayton PT.
    FEBS Lett; 2016 Jun 30; 590(11):1651-62. PubMed ID: 27139891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Searching, Structural Determination, and Diagnostic Performance Evaluation of Biomarker Molecules for Niemann-Pick Disease Type C Using Liquid Chromatography/Tandem Mass Spectrometry.
    Maekawa M, Mano N.
    Mass Spectrom (Tokyo); 2022 Jun 30; 11(1):A0111. PubMed ID: 36713801
    [Abstract] [Full Text] [Related]

  • 12. Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry.
    Maekawa M.
    Biol Pharm Bull; 2024 Jun 30; 47(6):1087-1105. PubMed ID: 38825462
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of Two Sulfated Cholesterol Metabolites Found in the Urine of a Patient with Niemann-Pick Disease Type C as Novel Candidate Diagnostic Markers.
    Maekawa M, Omura K, Sekiguchi S, Iida T, Saigusa D, Yamaguchi H, Mano N.
    Mass Spectrom (Tokyo); 2016 Jun 30; 5(2):S0053. PubMed ID: 27900236
    [Abstract] [Full Text] [Related]

  • 15. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.
    Jiang X, Sidhu R, Porter FD, Yanjanin NM, Speak AO, te Vruchte DT, Platt FM, Fujiwara H, Scherrer DE, Zhang J, Dietzen DJ, Schaffer JE, Ory DS.
    J Lipid Res; 2011 Jul 30; 52(7):1435-45. PubMed ID: 21518695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.
    Pajares S, Arias A, García-Villoria J, Macías-Vidal J, Ros E, de las Heras J, Girós M, Coll MJ, Ribes A.
    J Lipid Res; 2015 Oct 30; 56(10):1926-35. PubMed ID: 26239048
    [Abstract] [Full Text] [Related]

  • 18. Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism.
    Sitarska D, Ługowska A.
    Metab Brain Dis; 2019 Oct 30; 34(5):1253-1260. PubMed ID: 31197681
    [Abstract] [Full Text] [Related]

  • 19. Development of a bile acid-based newborn screen for Niemann-Pick disease type C.
    Jiang X, Sidhu R, Mydock-McGrane L, Hsu FF, Covey DF, Scherrer DE, Earley B, Gale SE, Farhat NY, Porter FD, Dietzen DJ, Orsini JJ, Berry-Kravis E, Zhang X, Reunert J, Marquardt T, Runz H, Giugliani R, Schaffer JE, Ory DS.
    Sci Transl Med; 2016 May 04; 8(337):337ra63. PubMed ID: 27147587
    [Abstract] [Full Text] [Related]

  • 20. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases.
    Kuchar L, Sikora J, Gulinello ME, Poupetova H, Lugowska A, Malinova V, Jahnova H, Asfaw B, Ledvinova J.
    Anal Biochem; 2017 May 15; 525():73-77. PubMed ID: 28259515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.